一项前瞻性临床研究,纳入2021年9月至2023年7月接受海曲泊帕联合环孢素A(CsA)治疗的24例TD-NSAA患者信息,将仅接受CsA单药治疗的79例患者作为历史对照。主要终点是 24 周时的总反应率(ORR,定义为≥1个谱系的血液学反应)。次要终点...
本次大会将报告奥雷巴替尼在CML(所有阶段)和Ph+ALL非中国患者中的安全性、有效性和药代动力学(PK)情况,尤其是在曾接受过普纳替尼和/或阿西米尼治疗的患者中。 截至2023年6月30日,共有76例患者入组,其中包括57例CML-CP患者和19例晚期Ph+白血病患者。患...
The ASH annual meeting virtual platform will open on Wednesday, December 6, 2023, to all attendees. Most sessions offered at the in-person meeting will be broadcast simultaneously on the virtual platform, and attendees will have the ability to ask questions and participate in real time. The pla...
与全球研究相比,疗效相当,安全性方面任意级别、2级和3级的NE均较低。 2023年第65届美国血液学会(ASH)年会于美国东部时间12月9日至12日在San Diego举行。ASH年会是全球血液学领域的国际盛会,本届大会汇集了各国知名血液病学专家最新的重要研究成果,已经公布7,000余篇已接受的摘要,其中CAR-T细胞治疗相关摘...
Joshua Richter, MD, of Mount Sinai, and other hematologic cancer experts join CancerNetwork following the 2023 ASH Annual Meeting & Exposition to discuss the biggest winner from the 2023 meeting.This is a modal window. The Playback API request failed for an unknown reason...
The ASH Annual Meeting has now passed Thank you to everyone who chose to participate in this year’s series of group meetings. We hope you found the updates and takeaways provided by the KOLs to be helpful. Be sure to check back as we get closer to next year’s event to learn more...
Joshua Richter, MD, led an enthusiastic panel with his colleagues in the multiple myeloma space following the 2023 ASH Annual Meeting and Exposition. The expert panel Joshua Richter, MD, led an enthusiastic panel with his colleagues in the multiple myeloma space...
[7]. Swetha Kambhampati, et al. Blood (2023) 142 (Supplement 1):107. [8]. Swetha Kambhampati, et al. 2023 ASH annual meeting. Oral presentation. [9]. Wang M, et al. J Clin Oncol. 2023;41(3):555-567. [10]. Swetha Kambhampati, et al. ASCO 2023. Oral presentation. ...
当地时间2023年11月2日,传奇生物(NASDAQ: LEGN)在美国新泽西州萨默塞特正式宣布,将于12月9日至12日在圣地亚哥举行的第65届美国血液学会年会暨博览会(American Society of Hematology Annual Meeting and Exposition ,简称ASH)上发表两场口头报告和五项壁报展示,公布西达基奥仑赛CARTITUDE临床开发项目的最新数据。
We summarized several latest reports of HIV associated lymphoma from the 2023 ASH Annual Meeting (ASH2023).doi:10.1186/s40164-024-00530-6Wang, ChaoyuXiao, QingZhang, XiaomeiLiu, YaoBioMed CentralExperimental Hematology & Oncology